SOLA Pharmaceuticals
PARISH: East Baton Rouge
INDUSTRY: Healthcare & Life Sciences
SOLA Pharmaceuticals is a Baton Rouge-based pharmaceutical company that develops and distributes generic prescription and over-the-counter medications. Founded in 2014, the company specializes in topical and transdermal drug products, including creams, gels, and patches, and operates from an FDA-approved, cGMP-certified headquarters and distribution center. Using proprietary, data-driven technology, SOLA identifies high-demand drug opportunities and rapidly brings products to market, serving pharmacies nationwide.
$15M
Capital Investment
30%+
U.S. Transdermal Patch Market Share
When SOLA Pharmaceuticals established and expanded its operations in Baton Rouge, the company leveraged the region’s growing life sciences sector, access to talent, and strategic logistics network. Since its founding, SOLA has grown significantly, building a portfolio of 24 drugs across 45 SKUs and positioning itself as the only FDA-approved pharmaceutical manufacturer headquartered in the Capital Region.
Driving Market Share and Patient Impact
As of 2026, SOLA produces an estimated 30% to 40% of the transdermal patches in the U.S. market and is planning a $15 million investment to establish its own patch manufacturing facility in Baton Rouge, further strengthening domestic production capabilities.
Beyond growth, SOLA has made a meaningful impact on patient access and affordability. The company became the first authorized generic manufacturer of a multiple sclerosis drug, dramatically reducing the cost from thousands of dollars per month to approximately $400 per year—prompting broader market price reductions and improving access for patients nationwide.
Similar Success Stories